Hearing Loss, Bilateral or UnilateralNCT06811610
Reliability of a Portable Audiometric Device Based on Active Noise-Canceling Headphones for Clinical Hearing Assessment
An observational study of Hearing Loss, Bilateral or Unilateral, run by Xijing Hospital at 1 site in China.
Trial summary
Part One: Research Background Globally, approximately 500 million people suffer from disabling hearing loss, accounting for about 6.8% of the world's population. Hearing loss has emerged as a major global health issue. The cornerstone of hearing loss prevention and protection lies in hearing level testing. Read more about this study
- Who is it for?
- Ages 6 years and olderHealthy volunteers can take part
- Conditions the study is for
- Hearing Loss, Bilateral or Unilateral
- What is being tested?
- Participants were tested for hearing using a new type of hearing detection device and Participants' hearing was tested using a new portable pure tone audiometry device
- How many people
- 120 participants
- Where
- 1 siteChina
- Study dates
- 29 Mar 2024to 30 Jun 2026
- How long will I take part?
- 1 Month
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 6 years and older
- All sexes
- Healthy volunteers accepted
- Child, Adult, Older adult
Study population: Volunteers who need hearing testing (pure tone audiometry) for various reasons or diseases are recruited from the ENT outpatient clinic or ward of Xijing Hospital
Who may be able to join
- Age:≥6 years old, regardless of gender
- Must be able to cooperate in completing pure tone audiometry
Who cannot join
- Acute phase of otitis media or external ear canal within the secretion blockage can not be removed
- Those suffering from mental illness or other reasons unable to cooperate with the completion of the examination Remarks: Each participant was examined by a specialist using otoscope. Those with ceruminous external auditory canal embolism or secretion blockage were cleared before audiological examination
Trial locations and contacts
1 site in 1 country.
China1 site, 1 recruiting
- Recruiting
The First Affiliated Hospital of the Air Force Medical University
Xi’an, Shanxi, 710000
dingjun zha, Doctor of Medicine, +8613609180861, zhadjun@fmmu.edu.cn
About this study
Part One: Research Background Globally, approximately 500 million people suffer from disabling hearing loss, accounting for about 6.8% of the world's population. Hearing loss has emerged as a major global health issue. The cornerstone of hearing loss prevention and protection lies in hearing level testing. Early detection and intervention are crucial components of hearing healthcare. Currently, pure tone audiometry serves as the gold standard for hearing level testing, requiring patients to visit a hospital's standard soundproof room and complete the test under the guidance of a professional audiologist. However, existing professional audiometers are bulky, consume high power, and necessitate soundproof rooms (with background noise <30dBA), among other drawbacks. Moreover, primary hospitals or units lack professional audiologists and soundproof rooms, making it impossible to diagnose and treat hearing loss. Therefore, a portable hearing testing device that does not require a soundproof room would be a boon for the diagnosis and treatment of hearing loss patients. Currently, Wuhan Douting Technology Co., Ltd. has produced a portable hearing testing device (E200), supporting frequencies from 125Hz to 16000Hz, covering both conventional and extended high frequencies. The frequency tolerance, total harmonic distortion, and accuracy of hearing levels fully meet the technical requirements of Grade 4 audiometers according to national standards. In addition to meeting the functional and performance requirements of general audiometers, this device offers the following technical advantages and innovations: 1. Combining active and passive noise reduction, it achieves comprehensive noise reduction of over 29dBSPL, allowing for audiometry in environments with background noise <60dBA; 2. Supporting extended high frequencies, it can detect potential hearing damage earlier; 3. Supporting audiometry for rapid use by non-professionals, with automatic calibration, allowing non-professionals to operate by following prompts. This device is not yet on the market, and we intend to verify its reliability in assessing hearing conditions.
Part Two: Research Objectives To verify the reliability of a novel portable hearing testing device in assessing hearing conditions.
Read more
Part Three: Research Design Paired design
Part Four: Inclusion and Exclusion Criteria
Inclusion Criteria:
Age: ≥6 years old, no gender restriction Able to cooperate in completing pure tone audiometry
Exclusion Criteria:
Patients with acute otitis media or unremovable secretions blocking the external auditory canal Patients with mental or psychological disorders or unable to cooperate with the examination for other reasons
Part Five: Research Process This study will recruit volunteers from the outpatient and inpatient departments of Xijing Hospital. Each volunteer will undergo two audiological tests, with at least a 10-minute interval between the two tests to prevent intolerance to the hearing tests. Each audiological test will take approximately 6-8 minutes per subject.
Consultation and Physical Examination:
Researchers will collect general information, including name, gender, age, hearing status, and ear disease history; Conduct a physical examination of the ears; If a volunteer meets the inclusion criteria and voluntarily sign the informed consent form, researchers will determine the testing order using a random number method based on your enrollment sequence.
Conventional pure-tone audiometry:Patients undergo conventional pure tone audiometry using the interacoustics AC40 (Denmark) with TDH39 headphones (Telephonics; Farmingdale, NY, USA). We conducte audiometric testing in a sound-proof booth (background noise<30dBA) and evaluate the frequency range of 125-8000 Hz. Before the audiometry, patients will be asked to identify which ear have better hearing, and the ear with better hearing was tested first. This study employ the Hughson-Westlake approach, known as the " up-5 down-10 technique." The pure tone sound level was initially introduced at an estimated higher threshold and reduced by 10 dB HL after a correct response from the patient. If the patient did not respond correctly or at all, the sound level was increased by 5 dB HL. When there was a difference of 40 dB HL or more in air conduction thresholds between the ears, contralateral masking was applied to correct the cross-hearing.
E200 Audiometry: Noise-canceling headphones (RAN-3500) are used for all patients during the E200 audiometry. This is conducted in a regular room (ambient noise: 42.6-58.7 dBA, measured using a standard sound level meter: AWA6292 Multi-function Sound Level Meter) adjacent to a busy hallway without a sound-proof booth to simulate an ordinary environment. The Hughson-Westlake approach and contralateral masking are applied when conducting the E200 audiometry.
Read the detailed description
Quality Control: Double-blind: The examiner does not have access to the results of the other testing technique until the experiment is completed, and the patient remains unaware of the results of both testing approaches until the end of the experiment.
Randomization: The sequence in which the patient undergoes the hearing tests is randomly determined using a random number table, ensuring an interval of at least 10 min between the two tests to avoid errors caused by fatigue or discomfort from consecutive testing.
Two individuals were responsible for entering the data, after which they verified each other's entries for accuracy.
Risks and Discomforts:
This study is a paired study utilizing a crossover trial method. All participants will undergo non-invasive procedures including basic information collection, medical history inquiry, physical examination, and pure tone audiometry. Pure tone audiometry, a standard outpatient clinical test, is conducted in a soundproof room. While this is a commonly used clinical examination method, an extremely small number of subjects may experience discomfort such as nervousness and anxiety due to不适应 to the enclosed environment. These symptoms can quickly subside once the subject leaves the environment and generally do not require special treatment. During the hearing test, pure tones are used. A minority of subjects with acoustic sensitivity may experience intolerance, ear pain, or other discomfort when exposed to louder sound stimuli. To mitigate this, the sound is gradually increased from a low volume during the examination. The researcher will closely monitor the subject's reactions, and if discomfort arises, the examination will be immediately halted. In most cases, symptoms will spontaneously resolve without special treatment after the examination is stopped. This study does not pose any additional risks to participants. For any adverse reactions that occur during the study, the researcher must accurately record them, promptly handle them according to medical protocols, and increase the frequency of follow-up visits or conduct additional laboratory tests based on the subject's condition. Follow-up should continue until the issue is properly resolved, the subject's condition stabilizes or returns to normal, or the researcher deems it appropriate to terminate follow-up.
Personal Information Confidentiality:
The information collected in this study will be kept confidential within the hospital as confidential material. To protect the identity of the subjects, any information related to the subjects in the research documents will be identified using a uniformly formatted number rather than names. Among all the collected and combined information of the subjects, any information that could help identify you will be removed to ensure that the relevant information cannot be linked to a specific research subject.
Sample Size Calculation: Based on the 69 data groups obtained in the pre-experiment, the Kappa coefficients were calculated as follows: left ear: 0.764, right ear: 0.743. A confidence level of 0.9 (α= 0.1) was used, and the confidence interval width was set to 0.2. The sample sizes computed using the PASS 2021 were determined to be 89 for the left ear and 107 for the right ear (eFigure 2 in Supplement 1). Ultimately, 114 patients were enrolled to validate the reliability of the E200.
Ethics: All patients provided written informed consent, and the study was approved by the Medical Ethics Committee of the First Affiliated Hospital of the Air Force Medical University(Ethics Committee FILE No: KY20242145-F-1). This study was conducted in accordance with the Declaration of Helsinki and Good Clinical Practice guidelines .
- Conditions
- Hearing Loss, Bilateral or Unilateral
- Being tested
- Participants were tested for hearing using a new type of hearing detection device, Participants' hearing was tested using a new portable pure tone audiometry device
- Medical subject headings
- Hearing Loss
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Participants were tested for hearing using a new type of hearing detection deviceDiagnostic test
Participants' hearing was tested using a portable audiometry device (E200) based on active noise-cancelling headphones, manufactured by Wuhan Doulisten Technology Co., LTD
Participants' hearing was tested using a new portable pure tone audiometry deviceDiagnostic test
Participants' hearing was tested using a portable audiometry device (E200) based on active noise-cancelling headphones, manufactured by Wuhan Doulisten Technology Co., LTD
What is being measured
The primary outcome is the main question the study is designed to answer.
Hearing thresholds of each frequency of two hearing detection methods
Each participant used standard soundproof room pure tone audiometry (gold standard) and a new portable audiometry. The hearing thresholds of each frequency obtained by the two methods were recorded for each volunteer and compared
Measured: 2024.03.29-2026.06.30
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted6 Feb 2025
- Study start29 Mar 2024
- Primary completion30 Jun 2026 (estimated)
- Study completion30 Jun 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Hearing Loss, Bilateral or UnilateralStudies of the same condition, open and under way.
- More trials run by Xijing HospitalThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case-control
- Time perspective
- Prospective
- Enrolment
- 120 participants (estimated)
- Target duration
- 1 Month
Sponsor and investigators
- Lead sponsor
- Xijing Hospital
- Sponsor type
- University, hospital or other
- Collaborators
- Wuhan Douting Technology Co., Ltd
- Responsible party
- Sponsor
- Investigators
- dingjun zha, Doctor of Medicine, Study director, Department of Otolaryngology, the First Affiliated Hospital of Air Force Medical University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06811610
- Sponsor's protocol ID
- KY20242145zhadingjun
- Status last verified
- Mar 2024
- First submitted
- 22 Jan 2025
- Last updated
- 6 Feb 2025
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: all data can be provided except for personal information of the volunteer
Publications
Lee SY, Seo HW, Jung SM, Lee SH, Chung JH. Assessing the accuracy and reliability of application-based audiometry for hearing evaluation. Sci Rep. 2024 Mar 28;14(1):7359. doi: 10.1038/s41598-024-57944-9.
PubMed 38548854
Study at a glance
From the registry record, last updated by the sponsor on 6 Feb 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Reliability of a Portable Audiometric Device Based on Active Noise-Canceling Headphones for Clinical Hearing Assessment
- ClinicalTrials.gov ID
- NCT06811610
- Acronym / sponsor ID
- KY20242145zhadingjun
- Conditions
- Hearing Loss, Bilateral or Unilateral
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 120 participants (estimated)
- Lead sponsor
- Xijing HospitalUniversity, hospital or other
- Collaborators
- Wuhan Douting Technology Co., Ltd
- Study start
- 29 Mar 2024 (actual)
- Primary completion
- 30 Jun 2026 (estimated)
- Study completion
- 30 Jun 2026 (estimated)
- First posted
- 6 Feb 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Part One: Research Background Globally, approximately 500 million people suffer from disabling hearing loss, accounting for about 6.8% of the world's population. Hearing loss has emerged as a major global health issue. The cornerstone of hearing loss prevention and protection lies in hearing level testing. Early detection and intervention are crucial components of hearing healthcare. Currently, pure tone audiometry serves as the gold standard for hearing level testing, requiring patients to visit a hospital's standard soundproof room and complete the test under the guidance of a professional audiologist. However, existing professional audiometers are bulky, consume high power, and necessitate soundproof rooms (with background noise <30dBA), among other drawbacks. Moreover, primary hospitals or units lack professional audiologists and soundproof rooms, making it impossible to diagnose and treat hearing loss. Therefore, a portable hearing testing device that does not require a soundproof room would be a boon for the diagnosis and treatment of hearing loss patients. Currently, Wuhan Douting Technology Co., Ltd. has produced a portable hearing testing device (E200), supporting frequencies from 125Hz to 16000Hz, covering both conventional and extended high frequencies. The frequency tolerance, total harmonic distortion, and accuracy of hearing levels fully meet the technical requirements of Grade 4 audiometers according to national standards. In addition to meeting the functional and performance requirements of general audiometers, this device offers the following technical advantages and innovations: 1. Combining active and passive noise reduction, it achieves comprehensive noise reduction of over 29dBSPL, allowing for audiometry in environments with background noise <60dBA; 2. Supporting extended high frequencies, it can detect potential hearing damage earlier; 3. Supporting audiometry for rapid use by non-professionals, with automatic calibration, allowing non-professionals to operate by following prompts. This device is not yet on the market, and we intend to verify its reliability in assessing hearing conditions.
Part Two: Research Objectives To verify the reliability of a novel portable hearing testing device in assessing hearing conditions.
Part Three: Research Design Paired design
Part Four: Inclusion and Exclusion Criteria
Inclusion Criteria:
Age: ≥6 years old, no gender restriction Able to cooperate in completing pure tone audiometry
Exclusion Criteria:
Patients with acute otitis media or unremovable secretions blocking the external auditory canal Patients with mental or psychological disorders or unable to cooperate with the examination for other reasons
Part Five: Research Process This study will recruit volunteers from the outpatient and inpatient departments of Xijing Hospital. Each volunteer will undergo two audiological tests, with at least a 10-minute interval between the two tests to prevent intolerance to the hearing tests. Each audiological test will take approximately 6-8 minutes per subject.
Consultation and Physical Examination:
Researchers will collect general information, including name, gender, age, hearing status, and ear disease history; Conduct a physical examination of the ears; If a volunteer meets the inclusion criteria and voluntarily sign the informed consent form, researchers will determine the testing order using a random number method based on your enrollment sequence.
Conventional pure-tone audiometry:Patients undergo conventional pure tone audiometry using the interacoustics AC40 (Denmark) with TDH39 headphones (Telephonics; Farmingdale, NY, USA). We conducte audiometric testing in a sound-proof booth (background noise<30dBA) and evaluate the frequency range of 125-8000 Hz. Before the audiometry, patients will be asked to identify which ear have better hearing, and the ear with better hearing was tested first. This study employ the Hughson-Westlake approach, known as the " up-5 down-10 technique." The pure tone sound level was initially introduced at an estimated higher threshold and reduced by 10 dB HL after a correct response from the patient. If the patient did not respond correctly or at all, the sound level was increased by 5 dB HL. When there was a difference of 40 dB HL or more in air conduction thresholds between the ears, contralateral masking was applied to correct the cross-hearing.
E200 Audiometry: Noise-canceling headphones (RAN-3500) are used for all patients during the E200 audiometry. This is conducted in a regular room (ambient noise: 42.6-58.7 dBA, measured using a standard sound level meter: AWA6292 Multi-function Sound Level Meter) adjacent to a busy hallway without a sound-proof booth to simulate an ordinary environment. The Hughson-Westlake approach and contralateral masking are applied when conducting the E200 audiometry.
Detailed description
Quality Control: Double-blind: The examiner does not have access to the results of the other testing technique until the experiment is completed, and the patient remains unaware of the results of both testing approaches until the end of the experiment.
Randomization: The sequence in which the patient undergoes the hearing tests is randomly determined using a random number table, ensuring an interval of at least 10 min between the two tests to avoid errors caused by fatigue or discomfort from consecutive testing.
Two individuals were responsible for entering the data, after which they verified each other's entries for accuracy.
Risks and Discomforts:
This study is a paired study utilizing a crossover trial method. All participants will undergo non-invasive procedures including basic information collection, medical history inquiry, physical examination, and pure tone audiometry. Pure tone audiometry, a standard outpatient clinical test, is conducted in a soundproof room. While this is a commonly used clinical examination method, an extremely small number of subjects may experience discomfort such as nervousness and anxiety due to不适应 to the enclosed environment. These symptoms can quickly subside once the subject leaves the environment and generally do not require special treatment. During the hearing test, pure tones are used. A minority of subjects with acoustic sensitivity may experience intolerance, ear pain, or other discomfort when exposed to louder sound stimuli. To mitigate this, the sound is gradually increased from a low volume during the examination. The researcher will closely monitor the subject's reactions, and if discomfort arises, the examination will be immediately halted. In most cases, symptoms will spontaneously resolve without special treatment after the examination is stopped. This study does not pose any additional risks to participants. For any adverse reactions that occur during the study, the researcher must accurately record them, promptly handle them according to medical protocols, and increase the frequency of follow-up visits or conduct additional laboratory tests based on the subject's condition. Follow-up should continue until the issue is properly resolved, the subject's condition stabilizes or returns to normal, or the researcher deems it appropriate to terminate follow-up.
Personal Information Confidentiality:
The information collected in this study will be kept confidential within the hospital as confidential material. To protect the identity of the subjects, any information related to the subjects in the research documents will be identified using a uniformly formatted number rather than names. Among all the collected and combined information of the subjects, any information that could help identify you will be removed to ensure that the relevant information cannot be linked to a specific research subject.
Sample Size Calculation: Based on the 69 data groups obtained in the pre-experiment, the Kappa coefficients were calculated as follows: left ear: 0.764, right ear: 0.743. A confidence level of 0.9 (α= 0.1) was used, and the confidence interval width was set to 0.2. The sample sizes computed using the PASS 2021 were determined to be 89 for the left ear and 107 for the right ear (eFigure 2 in Supplement 1). Ultimately, 114 patients were enrolled to validate the reliability of the E200.
Ethics: All patients provided written informed consent, and the study was approved by the Medical Ethics Committee of the First Affiliated Hospital of the Air Force Medical University(Ethics Committee FILE No: KY20242145-F-1). This study was conducted in accordance with the Declaration of Helsinki and Good Clinical Practice guidelines .
Study design
- Observational model
- Case-control
- Time perspective
- Prospective
- Target follow-up
- 1 Month
Who may qualify
- Ages
- 6 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
- Study population
- Volunteers who need hearing testing (pure tone audiometry) for various reasons or diseases are recruited from the ENT outpatient clinic or ward of Xijing Hospital
Key inclusion criteria (2 listed)
- Age:≥6 years old, regardless of gender
- Must be able to cooperate in completing pure tone audiometry
Key exclusion criteria (2 listed)
- Acute phase of otitis media or external ear canal within the secretion blockage can not be removed
- Those suffering from mental illness or other reasons unable to cooperate with the completion of the examination Remarks: Each participant was examined by a specialist using otoscope. Those with ceruminous external auditory canal embolism or secretion blockage were cleared before audiological examination
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Participants were tested for hearing using a new type of hearing detection deviceParticipants' hearing was tested using a portable audiometry device (E200) based on active noise-cancelling headphones, manufactured by Wuhan Doulisten Technology Co., LTD | Diagnostic test | – |
| Participants' hearing was tested using a new portable pure tone audiometry deviceParticipants' hearing was tested using a portable audiometry device (E200) based on active noise-cancelling headphones, manufactured by Wuhan Doulisten Technology Co., LTD | Diagnostic test | – |
Primary outcome
Hearing thresholds of each frequency of two hearing detection methods
Time frame: 2024.03.29-2026.06.30
Each participant used standard soundproof room pure tone audiometry (gold standard) and a new portable audiometry. The hearing thresholds of each frequency obtained by the two methods were recorded for each volunteer and compared
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 6 Feb 2025.
- Background: PubMed 38548854Lee SY, Seo HW, Jung SM, Lee SH, Chung JH. Assessing the accuracy and reliability of application-based audiometry for hearing evaluation. Sci Rep. 2024 Mar 28;14(1):7359. doi: 10.1038/s41598-024-57944-9.
- Individual participant dataSharing planned: Yes. all data can be provided except for personal information of the volunteer
Related trials for Hearing Loss, Bilateral or Unilateral
Recruiting
Towards Implementation of Universal Newborn Hearing Screening in Kenya
Hearing Loss, Bilateral or Unilateral, Otitis Media With Effusion in Children
RecruitingObservational study
Feasibility and Reliability of Integrating Electrically Evoked Stapedius Reflex Threshold (eSRT) Measurement in a Pediatric Cochlear Implant Programming Center
Hearing Loss in Children With Unilateral or Bilateral Cochlear Implants
Recruiting
Evaluating How a Tinnitus Implant Affects Tinnitus Loudness in Adults With Chronic Tinnitus and Varying Levels of Hearing Loss
Tinnitus, Hearing Loss, Bilateral or Unilateral
Active, not recruiting
A Study to Explore Improved Features and a Simplified Treatment Approach for a Totally Implantable Cochlear Implant (TICI) Research System in Adults With Severe Hearing Loss
Hearing Loss, Bilateral or Unilateral, Hearing Loss, Sensorineural
Not yet recruitingObservational study
Hearing Loss and Aid Attitudes in Health Sciences Students
Hearing Loss, Bilateral or Unilateral, Hearing Aid
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
dingjun zha, Doctor of Medicine study director
Department of Otolaryngology, the First Affiliated Hospital of Air Force Medical University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Hearing Loss, Bilateral or Unilateral, run by Xijing Hospital at 1 site in China.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 6 Feb 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact qianjin gao, medical postgraduate student (+86-19838825659, kydgao123@qq.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Hearing thresholds of each frequency of two hearing detection methods (time frame: 2024.03.29-2026.06.30). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06811610, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Feb 2025; AzTrials last refreshed its copy on 3 Nov 2026.